United States
Germany
Japan
United Kingdom
China
MAP2K1 mouse monoclonal antibody,clone OTI4E1
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Products
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI3H3 (formerly 3H3)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CNY 3,990.00
2周
CNY 3,990.00
2周
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI7E2 (formerly 7E2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI2D4 (formerly 2D4)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI2B2 (formerly 2B2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI8A6 (formerly 8A6)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI3E6 (formerly 3E6)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Mouse, Rat |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI4F1 (formerly 4F1)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Mouse |
活动过滤器
优化搜索结果
Category
Applications
Antibody Hosts
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
Brands
Pathways
- Acute myeloid leukemia (233)
- B cell receptor signaling pathway (233)
- Bladder cancer (233)
- Chemokine signaling pathway (233)
- Chronic myeloid leukemia (233)
- Colorectal cancer (233)
- Dorso-ventral axis formation (233)
- Endometrial cancer (233)
- ErbB signaling pathway (233)
- Fc epsilon RI signaling pathway (233)
- Fc gamma R-mediated phagocytosis (233)
- Focal adhesion (233)
- Gap junction (233)
- Glioma (233)
- GnRH signaling pathway (233)
- Insulin signaling pathway (233)
- Long-term depression (233)
- Long-term potentiation (233)
- MAPK signaling pathway (233)
- Melanogenesis (233)
- Melanoma (233)
- Natural killer cell mediated cytotoxicity (233)
- Neurotrophin signaling pathway (233)
- Non-small cell lung cancer (233)
- Oocyte meiosis (233)
- Pancreatic cancer (233)
- Pathways in cancer (233)
- Prion diseases (233)
- Progesterone-mediated oocyte maturation (233)
- Prostate cancer (233)
- Regulation of actin cytoskeleton (233)
- Renal cell carcinoma (233)
- T cell receptor signaling pathway (233)
- Thyroid cancer (233)
- Toll-like receptor signaling pathway (233)
- VEGF signaling pathway (233)
- Vascular smooth muscle contraction (233)
